Skip to content
Search

Latest Stories

Pharmacy needs further support in Scotland, Wales to fight Covid-19: RPS

The Royal Pharmaceutical Society (RPS) has urged the Scottish and Welsh governments to take further action to support pharmacy sector amid the spread of deadly Covid-19.

In letters to Jeane Freeman, Scottish cabinet secretary for health and sport, and Vaughan Gething, Welsh health minister, RPS shared its policy asks, which outline the areas where pharmacy needs governments’ support.


RPS urged the governments to provide adequate supplies of quality personal protection equipment (PPE) for pharmacy teams and make Covid-19 testing a priority for community pharmacies.

RPS stressed the need for absolute clarity in public messaging around use of healthcare services including specifically naming pharmacies when talking about avoiding unnecessary visits and keeping social distancing.

"We would encourage you to continue to show how much you value pharmacy and to take every opportunity to include them in your communications and guidance. This will not only help bolster our profession through difficult times but will also help to educate the public on what to expect from their pharmacy teams at this time,” Jonathan Burton, chair of RPS in Scotland, said.

Elen Jones, RPS director for Wales, added: “The role of community pharmacy is becoming ever more important in the fight against this virus and in maintaining the supply of medicines to patients across Wales. The continued support of the Welsh Government for pharmacy teams across Wales is now critical."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less